account_balance
Investment manager · 13F filer · SEC CIK 1469336
Empery Asset Management, LP
Reported value$86.5Mas of Jun 30, 2026
Positions32 12 new, 12 sold out
Top 10 weight90.7%XFOR alone is 37%
FiledAug 1142 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
XFORX4 Pharmaceuticals Inc
37.4%Trimmed −23%
EMPDEmpery Digital Inc
12.1%
NGENNervgen Pharma Corp
9.5%New
DTILPrecision Biosciences Inc
7.1%Trimmed −61%
CLNNClene Inc
6.5%New
ANVSAnnovis Bio Inc
5.2%New
LTRNLantern Pharma Inc
4.1%New
AMCAmc Entmt Hldgs Inc
3.8%New
TNYATenaya Therapeutics Inc
3.3%Trimmed −10%
YDDL1.8%CYNCyngn Inc
1.5%Trimmed −3%
VENU1.3%XFORX4 Pharmaceuticals Inc
37.4%Trimmed −23%
EMPDEmpery Digital Inc
12.1%
NGENNervgen Pharma Corp
9.5%New
DTIL7.1%CLNN6.5%ANVS5.2%LTRN4.1%AMC3.8%TNYA3.3%YDDLCYNBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
XFOR X4 Pharmaceuticals Inc 37.4% Trimmed −23%EMPD Empery Digital Inc 12.1% HeldNGEN Nervgen Pharma Corp 9.5% NewDTIL Precision Biosciences Inc 7.1% Trimmed −61%CLNN Clene Inc 6.5% NewANVS Annovis Bio Inc 5.2% NewLTRN Lantern Pharma Inc 4.1% NewAMC Amc Entmt Hldgs Inc 3.8% NewTNYA Tenaya Therapeutics Inc 3.3% Trimmed −10%YDDL One and One Green Technologi 1.8% NewCYN Cyngn Inc 1.5% Trimmed −3%VENU Venu HLDG Corp 1.3% Trimmed −49%
What changed